These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 22522117)
1. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK; Shin HJ; Ha DH Eur J Pharm Sci; 2012 Aug; 46(5):500-7. PubMed ID: 22522117 [TBL] [Abstract][Full Text] [Related]
2. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Qiang F; Shin HJ; Lee BJ; Han HK Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082 [TBL] [Abstract][Full Text] [Related]
3. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization. Jung IW; Han HK Int J Nanomedicine; 2014; 9():2299-306. PubMed ID: 24872692 [TBL] [Abstract][Full Text] [Related]
4. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. Shao Y; Yang L; Han HK Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680 [TBL] [Abstract][Full Text] [Related]
5. Alendronate-loaded microparticles for improvement of intestinal cellular absorption. Baek JS; Kwon HH; Hwang JS; Sung HC; Lee JM; Shin SC; Kim YR; Cho CW J Drug Target; 2011 Jan; 19(1):37-48. PubMed ID: 20477555 [TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel. Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431 [TBL] [Abstract][Full Text] [Related]
7. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin. Huang A; Makhlof A; Ping Q; Tozuka Y; Takeuchi H Drug Deliv; 2011 Nov; 18(8):562-9. PubMed ID: 21823926 [TBL] [Abstract][Full Text] [Related]
8. Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis. Hosny KM; Ahmed OA; Al-Abdali RT Expert Opin Drug Deliv; 2013 Jun; 10(6):741-6. PubMed ID: 23656470 [TBL] [Abstract][Full Text] [Related]
9. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system. Zhou Y; Ning Q; Yu DN; Li WG; Deng J J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348 [TBL] [Abstract][Full Text] [Related]
11. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976 [TBL] [Abstract][Full Text] [Related]
12. Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties. Gradauer K; Vonach C; Leitinger G; Kolb D; Fröhlich E; Roblegg E; Bernkop-Schnürch A; Prassl R Int J Nanomedicine; 2012; 7():2523-34. PubMed ID: 22679365 [TBL] [Abstract][Full Text] [Related]
13. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome. Zhao M; Lee SH; Song JG; Kim HY; Han HK Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795 [TBL] [Abstract][Full Text] [Related]
14. Improving oral bioavailability and pharmacokinetics of liposomal metformin by glycerolphosphate-chitosan microcomplexation. Manconi M; Nácher A; Merino V; Merino-Sanjuan M; Manca ML; Mura C; Mura S; Fadda AM; Diez-Sales O AAPS PharmSciTech; 2013 Jun; 14(2):485-96. PubMed ID: 23471836 [TBL] [Abstract][Full Text] [Related]
15. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment. Meng J; Hu L J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388 [TBL] [Abstract][Full Text] [Related]
16. Conjugation of poorly absorptive drugs with mucoadhesive polymers for the improvement of oral absorption of drugs. Sakuma S; Matsumoto T; Yamashita S; Wang Y; Lu ZR J Control Release; 2007 Nov; 123(3):195-202. PubMed ID: 17888541 [TBL] [Abstract][Full Text] [Related]
17. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats. Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424 [TBL] [Abstract][Full Text] [Related]
18. High payload nanostructured lipid carriers fabricated with alendronate/polyethyleneimine ion complexes. Abd El-Hamid BN; Swarnakar NK; Soliman GM; Attia MA; Pauletti GM Int J Pharm; 2018 Jan; 535(1-2):148-156. PubMed ID: 29104057 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models. Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]